Rabies Postexposure Prophylaxis Management

Key Principles

The Centers for Disease Control and Prevention recommends that rabies postexposure prophylaxis should not be interrupted or discontinued because of mild systemic adverse reactions such as fever from an upper respiratory infection 1, 2
Rabies prophylaxis must proceed without interruption regardless of concurrent mild illnesses like upper respiratory infections with fever, as the risk of rabies far outweighs any concerns about administering vaccine during a minor febrile illness 1, 2, 3, 4
Local or mild systemic reactions—including fever—are not contraindications to continuing the vaccine series, according to the Advisory Committee on Immunization Practices 1, 2, 5

The patient's fever and URI symptoms can be managed with anti-inflammatory and antipyretic agents such as ibuprofen or acetaminophen, which can be given before or after vaccination to improve patient comfort without compromising vaccine efficacy 2, 3, 4
Antihistamines may also be considered if needed for symptom management, as recommended by the Centers for Disease Control and Prevention 2, 3

There are no true contraindications to rabies postexposure prophylaxis once initiated, given the uniformly fatal nature of rabies, as stated by the Advisory Committee on Immunization Practices 1, 2
Interrupting the vaccine series could leave the patient vulnerable during the critical window before adequate antibody response develops, highlighting the importance of completing the full series 1, 6

The Advisory Committee on Immunization Practices recommends administering the second rabies vaccine dose as scheduled, providing symptomatic treatment for the URI and fever, and reassuring the patient that mild illness does not compromise vaccine effectiveness 1, 2
The patient should complete the full 4-dose series (days 0, 3, 7, 14) for previously unvaccinated persons, as recommended by the Centers for Disease Control and Prevention 1, 2, 3